Bacteriophage compositions for treating staphylococcus infection
AssigneeArmata Pharmaceuticals, Inc.
InventorsStacey Lynn KOLAR, Brian C. VARNUM
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to bacteriophages and compositions capable of infecting and killing Staphylococcus, and use of the same for treating Staphylococcus, e.g. Staphylococcus aureus, bacterial infections.
Claims31
1-69. (canceled)
A method for treating a bacterial infection comprising administering to a subject in need of treatment a bacteriophage composition comprising one or more bacteriophages selected from a bacteriophage comprising a polynucleotide sequence with at least 90% identity to SEQ ID NO:1, and a bacteriophage comprising a polynucleotide sequence with at least 90% identity to SEQ ID NO:2, wherein the composition comprises between 1×108 and 1×1011 PFU of each bacteriophage.
Dependencies are inferred from the claim text.